Literature DB >> 24378427

Multimodal imaging in deferoxamine retinopathy.

Francesco Viola1, Giulio Barteselli, Laura DellʼArti, Diego Vezzola, Chiara Mapelli, Edoardo Villani, Roberto Ratiglia.   

Abstract

PURPOSE: To describe macular lesions in patients with deferoxamine (DFO) retinopathy, and to follow their clinical course using multimodal imaging.
METHODS: The authors retrospectively reviewed charts and multimodal imaging of 20 patients with β-thalassemia diagnosed with DFO retinopathy (40 eyes) after a minimum of 10 years of DFO treatment. Imaging included fundus photography, near-infrared reflectance and fundus autofluorescence imaging on confocal laser scanning ophthalmoscope, and spectral domain optical coherence tomography.
RESULTS: Mean age of the 20 patients was 45 years, and mean duration of subcutaneous DFO therapy was 32 years (range, 20-52 years). Ten patients (50%) showed different types of pattern dystrophy-like fundus changes, including butterfly shaped-like (n = 3), fundus flavimaculatus-like (n = 3), fundus pulverulentus-like (n = 3), and vitelliform-like (n = 1) changes. Ten patients (50%) presented only minimal changes in the macula; these patients were significantly younger than patients presenting other patterns (P = 0.023). Confocal laser scanning ophthalmoscope and spectral domain optical coherence tomography showed that these abnormalities were more diverse and widespread than expected by ophthalmoscopy. Abnormal fundus autofluorescence and/or near-infrared reflectance signals corresponded to accumulation of material located within the outer retina or in the Bruch membrane-retinal pigment epithelium (RPE) complex on spectral domain optical coherence tomography. Follow-up examinations during a 40-month period revealed progressive development of RPE atrophy in areas of pattern dystrophy-like changes.
CONCLUSION: DFO retinopathy included a variety of pattern dystrophy-like changes or minimal changes affecting the RPE-Bruch membrane-photoreceptor complex. Multimodal imaging demonstrated that fundus changes were more diverse and widespread than expected from ophthalmoscopy. Consistently with previous histologic description of DFO retinopathy, multimodal imaging confirmed that photoreceptor outer-derived retinoids, various fluorophores, and RPE displacement or clumping are involved in DFO retinopathy, finally leading to frank RPE atrophy in most cases of pattern dystrophy-like changes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24378427     DOI: 10.1097/IAE.0000000000000073

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  15 in total

Review 1.  Bestrophin 1 and retinal disease.

Authors:  Adiv A Johnson; Karina E Guziewicz; C Justin Lee; Ravi C Kalathur; Jose S Pulido; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Prog Retin Eye Res       Date:  2017-01-30       Impact factor: 21.198

Review 2.  Ocular abnormalities in beta thalassemia patients: prevalence, impact, and management strategies.

Authors:  Samira Heydarian; Reza Jafari; Kiumars Nowroozpoor Dailami; Hassan Hashemi; Ebrahim Jafarzadehpour; Mohsen Heirani; Abbasali Yekta; Monireh Mahjoob; Mehdi Khabazkhoob
Journal:  Int Ophthalmol       Date:  2019-10-10       Impact factor: 2.031

3.  Pseudovitelliform maculopathy associated with deferoxamine toxicity: multimodal imaging and electrophysiology of a rare entity.

Authors:  Kelly M Bui; SriniVas R Sadda; Hani Salehi-Had
Journal:  Digit J Ophthalmol       Date:  2017-02-13

4.  Optical coherence tomography findings in patients with transfusion-dependent β-thalassemia.

Authors:  Sezaneh Haghpanah; Omid Reza Zekavat; Sanaz Safaei; Mohammad Ali Ashraf; Shirin Parand; Hossein Ashraf
Journal:  BMC Ophthalmol       Date:  2022-06-24       Impact factor: 2.086

Review 5.  Retinal abnormalities in β-thalassemia major.

Authors:  Devang L Bhoiwala; Joshua L Dunaief
Journal:  Surv Ophthalmol       Date:  2015-08-29       Impact factor: 6.048

Review 6.  Functional and Structural Abnormalities in Deferoxamine Retinopathy: A Review of the Literature.

Authors:  Maura Di Nicola; Giulio Barteselli; Laura Dell'Arti; Roberto Ratiglia; Francesco Viola
Journal:  Biomed Res Int       Date:  2015-06-08       Impact factor: 3.411

Review 7.  β-Thalassemia and ocular implications: a systematic review.

Authors:  Aliki Liaska; Petros Petrou; Constantinos D Georgakopoulos; Ramza Diamanti; Dimitris Papaconstantinou; Menelaos G Kanakis; Ilias Georgalas
Journal:  BMC Ophthalmol       Date:  2016-07-08       Impact factor: 2.209

8.  Iron overload and iron chelating agent exposure in anemia-associated outer retinal degeneration: a case report and review of the literature.

Authors:  Mohamed Belmouhand; Christina Eckmann-Hansen; Tomas Ilginis; Eva Birgitte Leinøe; Bo Kok Mortensen; Michael Larsen
Journal:  BMC Ophthalmol       Date:  2021-07-13       Impact factor: 2.209

9.  Pattern dystrophies in patients treated with deferoxamine: report of two cases and review of the literature.

Authors:  Constantine D Georgakopoulos; Foteini Tsapardoni; Elli V Kostopoulou; Olga E Makri
Journal:  BMC Ophthalmol       Date:  2018-09-12       Impact factor: 2.209

10.  Multimodal Chorioretinal Imaging in Erdheim-Chester Disease.

Authors:  Riccardo Sacconi; Corrado Campochiaro; Alessandro Rabiolo; Lorenzo Dagna; Giuseppe Querques; Alessandro Marchese; Alessandro Tomelleri; Livia Tomasso; Maria Vittoria Cicinelli; Lea Querques; Francesco Bandello
Journal:  Clin Ophthalmol       Date:  2020-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.